It’s pretty safe to say that most people know the heart is a very significant organ in the body. However many of us neglect this organ year after year. Over half a million individuals die from cardiovascular disease every year. Statistics like this back up the claim that heart disease is the leading cause death for both men and women. A really important fact of this research is that many of these deaths could’ve been prevented with the proper self care.
Though preventative screening tests are often overlooked they are essential to maintaining as healthy a life as possible. These test can have positive results that affect a person both physically and mentally. For example, an individual who has went through screening can be motivated to make behavioral lifestyle changes. Not to mention, that these tests can find issues and treat them become they become life threatening.
Lifeline Screening, a privately run provider of preventative health screenings based in Texas performed a survey focused on cardiovascular screenings that showed participants in the screenings made much healthier lifestyle choices afterwards. The study group consisted of 3,000, mostly senior citizen females. The study also showed no matter the results of the screening, participants were motivated to take better care of themselves.
Though it has already been mentioned in this article there’s a real need to reiterate the importance of cardiovascular screenings. Most people who are diagnosed with heart disease have had the issue for a long time before their diagnosis. The reason why is that symptoms of heart disease don’t occur until real damage has been done to the organ. This has led to the disease being coined the “silent killer.” Cardiovascular screenings are relatively easy and simple to register for.
About Lifeline Screenings
Lifeline Screenings hopes to encourage people to do preventative health screenings by making the process as fast and affordable as possible. The wellness company provided three main types of of testing including, finger stick blood tests, ultrasound screenings, and electrocardiograph.
Lifeline Screenings is doing a great job of raising awareness about this very dangerous disease. Awareness is vital considering how many lives this disease claims in the U.S.
Lifeline Screenings info: www.lifelinescreening.com/What-We-Do
Cancer has been a menace to many for the past few decades. The biggest dream for the 21st century scientist and especially medical researchers is to figure out the exact cause of cancer and if possible, get a treatment for it. The fight has become a serious concern for many; governments are giving more funds to institutions that carry out cancer research and the FDA is working over time to look into the feasibility of the medicines and therapies being proposed to them. one of the people that have been in the frontline in looking for a suitable treatment for cancer is Mikhail Blagosklonny, an Oncology professor at the Roswell Park Cancer Institute located in New York.
Mikhail started his journey in medical research back in his home country of Russia. He attended the First Pavlov state Medical University and attained his MD and PhD in medicine and cardiology. The first job that he got when he arrived in the US was the post of an associate professor at the New York Medical College. This was followed by an appointment to the post of researcher at the Ordway Research Institute in Albany, New York. He got the appointment to his current job in 2008. His current research is mainly connected with aging and longevity, cancer cells and the therapies that can help in the protection of the healthy cells from getting the damages that are caused by cancer.
He has come up with a therapy that he believes will work in the treatment of cancer. This involves the use of Rampamycin, a medicine that has for a long time been used for the treatment of cancer, and especially on the patients in order to prolong their lives. He has been a very strong advocate for the use of the drug in cancer therapy. He has many articles published in journals and other publications about the same subject. He is currently an editor and contributing author for Aging Magazine, Cell Cycle magazine and Onctarget. The journal is peer reviewed and is published by Impact Journals. He contributes to the editorial board at Cell Death and Differentiation Magazine. He has many publications to his name and is working to see that human life is extended through the use of the right therapies.
Follow Oncotarget journal on Twitter.